REGENXBIO Inc. (FRA:RB0)
Germany
· Delayed Price · Currency is EUR 11.20
+0.30 (2.75%)
Last updated: Dec 5, 2025, 8:02 AM CET
REGENXBIO Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 161.32 | 83.33 | 90.24 | 112.72 | 470.35 | 154.57 | Upgrade
|
| Revenue | 161.32 | 83.33 | 90.24 | 112.72 | 470.35 | 154.57 | Upgrade
|
| Revenue Growth (YoY) | 91.30% | -7.66% | -19.94% | -76.03% | 204.30% | 338.70% | Upgrade
|
| Cost of Revenue | 239.76 | 242.09 | 266.48 | 297 | 233.27 | 202.01 | Upgrade
|
| Gross Profit | -78.44 | -158.76 | -176.24 | -184.27 | 237.08 | -47.44 | Upgrade
|
| Selling, General & Admin | 80.53 | 76.62 | 87.79 | 85.28 | 79.33 | 63.82 | Upgrade
|
| Other Operating Expenses | 0.96 | 0.87 | 0.4 | -14.18 | 0.33 | 0.3 | Upgrade
|
| Operating Expenses | 76.49 | 72.48 | 88.19 | 71.1 | 77.1 | 71.79 | Upgrade
|
| Operating Income | -154.93 | -231.25 | -264.43 | -255.38 | 159.98 | -119.23 | Upgrade
|
| Interest Expense | -42.15 | -12.66 | -6.86 | -23.25 | -26.28 | -0.77 | Upgrade
|
| Interest & Investment Income | 19.16 | 18.9 | 11.34 | 5.73 | 7.54 | 13.99 | Upgrade
|
| EBT Excluding Unusual Items | -177.92 | -225 | -259.95 | -272.91 | 141.25 | -106.01 | Upgrade
|
| Merger & Restructuring Charges | - | - | -3.7 | - | - | - | Upgrade
|
| Asset Writedown | - | -2.1 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -7.5 | - | - | Upgrade
|
| Pretax Income | -177.92 | -227.1 | -263.65 | -280.41 | 141.25 | -106.01 | Upgrade
|
| Income Tax Expense | - | - | -0.15 | -0.08 | 13.41 | 5.24 | Upgrade
|
| Net Income | -177.92 | -227.1 | -263.49 | -280.32 | 127.84 | -111.25 | Upgrade
|
| Net Income to Common | -177.92 | -227.1 | -263.49 | -280.32 | 127.84 | -111.25 | Upgrade
|
| Shares Outstanding (Basic) | 51 | 50 | 44 | 43 | 42 | 37 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 50 | 44 | 43 | 44 | 37 | Upgrade
|
| Shares Change (YoY) | 7.46% | 13.21% | 1.35% | -1.73% | 17.79% | 1.61% | Upgrade
|
| EPS (Basic) | -3.46 | -4.59 | -6.02 | -6.50 | 3.01 | -2.98 | Upgrade
|
| EPS (Diluted) | -3.46 | -4.59 | -6.02 | -6.50 | 2.91 | -2.98 | Upgrade
|
| Free Cash Flow | -106.28 | -175.56 | -228.37 | -238.21 | 134.7 | -80.93 | Upgrade
|
| Free Cash Flow Per Share | -2.07 | -3.55 | -5.22 | -5.52 | 3.07 | -2.17 | Upgrade
|
| Gross Margin | -48.62% | -190.53% | -195.29% | -163.47% | 50.41% | -30.69% | Upgrade
|
| Operating Margin | -96.04% | -277.51% | -293.02% | -226.55% | 34.01% | -77.14% | Upgrade
|
| Profit Margin | -110.29% | -272.54% | -291.99% | -248.68% | 27.18% | -71.97% | Upgrade
|
| Free Cash Flow Margin | -65.88% | -210.69% | -253.06% | -211.32% | 28.64% | -52.36% | Upgrade
|
| EBITDA | -139.16 | -215.03 | -247.11 | -242.47 | 169.54 | -110.83 | Upgrade
|
| EBITDA Margin | -86.27% | -258.05% | -273.83% | -215.10% | 36.05% | -71.70% | Upgrade
|
| D&A For EBITDA | 15.77 | 16.22 | 17.32 | 12.91 | 9.56 | 8.41 | Upgrade
|
| EBIT | -154.93 | -231.25 | -264.43 | -255.38 | 159.98 | -119.23 | Upgrade
|
| EBIT Margin | -96.04% | -277.51% | -293.02% | -226.55% | 34.01% | -77.14% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 9.49% | - | Upgrade
|
| Revenue as Reported | 161.32 | 83.33 | 90.24 | 112.72 | 470.35 | 154.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.